INJ. BLEOCARE 15 IU

INJ. BLEOCARE 15 IU
Product Description

USE IN-- SQUAMOUS CELL CARCINOMA AFFECTING HEAD AND NECK.- HODGKIN'S AND NON- HODGKIN'S LYMPHOMA.
- TESTICULAR CARCINOMA.

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
Specifications

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail

More Products from RMPL Pharma LLP (99)

  • INJ. CANZATAX 100 MG

    Product INJ. CANZATAX 100 MG

    WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA :-
    USE IN - BREAST CARCINOMA                
    CERVICAL CARCINOMA           
    LUNG CARCINOMA           ...
  • INJ. CANZATAX 260 MG

    Product INJ. CANZATAX 260 MG

    WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA 
    USE IN - BREAST CARCINOMA                CERVICAL CARCINOMA               
    LUNG CARCINOMA        ...
  • INJ. CANZATAX 300 MG

    Product INJ. CANZATAX 300 MG

    WEEKLY ADMINISTRATION OF PACLITAXEL IS HIGHLY ACTIVE AND WELL TOLERATED IN BREST CARCINOMA 
    USE IN - BREAST CARCINOMA                CERVICAL CARCINOMA               
    LUNG CARCINOMA      &n...
  • INJ. ARACYT 100 MG

    Product INJ. ARACYT 100 MG

    . FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
    .BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
    . NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
    . INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHYLAXIS AND ...
  • INJ. ARACYT 1000 MG

    Product INJ. ARACYT 1000 MG

     FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
    .BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
    . NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
    . INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHY...
  • INJ. ARACYT 500 MG

    Product INJ. ARACYT 500 MG

     FOR REMISSION INDUCTION IN ACUTE NON LYMPHOCYCTIC LEUKEMIA OF BOTH ADULT AND CHILDREN..ACUTE MYELOCYTIC LEUKEMIA
    .BLAST PHASE OF CHRONIC MYELOCYTIC LEUKEMIA
    . NON HODGKING'S LYMPHOMA IN ADULT AND CHILDREAN
    . INTHRATHECAL ADMINISTRATION OF CYTARABINE INJECTION IS INDICATED IN THE PROPHY...
  • INJ. CANCYT 1 GM

    Product INJ. CANCYT 1 GM

    USED TO TREAT CANCER OF THE BLADDER, PANCREAS , OVARY AND BREAST, AND NON- SMALL CELL LUNG CANCER.
  • INJ. CANCYTE 200 MG

    Product INJ. CANCYTE 200 MG

    USED TO TREAT CANCER OF THE BLADDER, PANCREAS , OVARY AND BREAST, AND NON- SMALL CELL LUNG CANCER.
  • INJ. CANPLATIN 10 MG

    Product INJ. CANPLATIN 10 MG

    USED IN - - METASTATIC OVARIAN CANCER
    - ADVANCED BLADDER CANCER
    - METASTATIC TESTICULAR CANCER
  • INJ. CANPLATIN 50 MG

    Product INJ. CANPLATIN 50 MG

    USED IN - - METASTATIC OVARIAN CANCER
    - ADVANCED BLADDER CANCER
    - METASTATIC TESTICULAR CANCER
  • INJ. COSMEDAC 0.5 MG

    Product INJ. COSMEDAC 0.5 MG

    USE IN -- WILM'S TUMOUR
    - CHILDHOOD RHABDOMYOSARCOMA
    - EWING'S SARCOMA AND METASTATIC NONSEMINOMATOUS TESTICULAR CANCER
    - GESTATIONAL TROPHOBLASTIC NEOPLASIA. 
  • CAP. ETOPOSIDE 50 MG

    Product CAP. ETOPOSIDE 50 MG

    Etoposide s a chemotherapy medication used for the treatments of a number of types of cancer.[1] This includes testicular cancer, lung cancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer

RMPL Pharma LLP resources (1)

  • Brochure RMPL PHARMA LLP.

    The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.